General
Placing of first orders by new customers and confirmation of them by the Company shall be in writing for legal validity. This request for the written form shall equally apply to an…
en
Placing of first orders by new customers and confirmation of them by the Company shall be in writing for legal validity. This request for the written form shall equally apply to any amendment or modification or collateral agreement to the Company’s original quotation. Additional orders may be placed by mail, fax, phone or e-mail. Please, bear in mind that all orders will be handled on the basis of our General Standard Terms and Conditions.
A flat rate of € 25.00 plus € 21.00 for refrigeration, if necessary, will be charged for shipment within the territory of the Federal Republic of Germany. Real expenses will be charged for any delivery beyond the German border. A mark-up of € 25.00 will be charged for any small-volume purchase worth up to € 200.00.
The following details should be provided together with an order:
provitro AG
Charité Campus Mitte
Charitéplatz 1
10117 Berlin, Germany
Tel: +49 30 450 578 358
Fax: +49 30 450 578 952
E-mail: sales@provitro.de
www.provitro.com
www.provitro.de
www.provitro.jp
If products have been reserved for delivery, please add to your order reservation and batch number(s) of the product(s) reserved.
Orders placed in response to special offers, call-forward orders and bonus agreements must carry the applicable code numbers to ensure that you will enjoy the conditions agreed in the first place.
Placing of first orders by new customers and confirmation of them by the Company shall be in writing for legal validity. This request for the written form shall equally apply to an…
Read more
We recommend to use the Adobe Acrobat Reader for the best experience.
Copyright: 2020 provitro AG,
Charitéplatz 1, 10117 Berlin
provitro AG
Charitéplatz 1, 10117 Berlin
Tel:
+49.30.450 578 358
Email:
sales@provitro.com
Provitro stands for more than ten years of experience in commercialisation of cell culture technologies and tissue microarrays backed up by scientific knowledge and resources of immunohistochemical analyses at the Pathological Institute of Charité Universitätsmedizin Berlin. We have added medical research to our own know-how in biotechnology to create solutions to common problems in life sciences. Provitro’s team has raised its sights to the interface between research and development to hammer out brand-new solutions to the benefit of future research projects. These are the hallmarks: competence, vision and sustainability.